These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 17573671

  • 1. Predictive medicine: incipient reality or fata morgana?
    Dietel M.
    J Pathol; 2007 Aug; 212(4):353-5. PubMed ID: 17573671
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
    Modjtahedi H, Essapen S.
    Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
    Le Tourneau C, Vidal L, Siu LL.
    Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E, Ciardiello F.
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract] [Full Text] [Related]

  • 8. Molecular-based choice of cancer therapy: realities and expectations.
    Imyanitov EN, Moiseyenko VM.
    Clin Chim Acta; 2007 Apr; 379(1-2):1-13. PubMed ID: 17306783
    [Abstract] [Full Text] [Related]

  • 9. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR, Johnson BE, Sledge GW.
    Clin Cancer Res; 2012 Feb 01; 18(3):619-24. PubMed ID: 22298894
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predictive tests for the response to cancer chemotherapy: limitations related to the prediction of rare events.
    Rozencweig M, Staquet M.
    Cancer Treat Rep; 1984 Apr 01; 68(4):611-3. PubMed ID: 6713417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cancer biomarkers. Preface.
    Dixit R, Srivastava S.
    Cancer Biomark; 2005 Apr 01; 1(1):3-4. PubMed ID: 17203571
    [No Abstract] [Full Text] [Related]

  • 17. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
    O'Connor R, Clynes M, Dowling P, O'Donovan N, O'Driscoll L.
    Expert Opin Drug Metab Toxicol; 2007 Dec 01; 3(6):805-17. PubMed ID: 18028026
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.